Roche, Genentech in talks on $47 billion deal
NEW YORK (Reuters) - Roche Holding AG has sweetened its offer for Genentech Inc by about 2 percent to $46.7 billion, a source familiar with the situation said, as Roche pushes to take full control of the biotech after an eight-month courtship.<div class="feedflare">
<img src="http://feeds2.feedburner.com/~ff/reuters/businessNews?d=yIl2AUoC8zA" border="0"></img> (http://feeds.reuters.com/~ff/reuters/businessNews?a=IFmsFJoNbL0:AkzsYyczbVQ:yIl2AUoC8zA) <img src="http://feeds2.feedburner.com/~ff/reuters/businessNews?i=IFmsFJoNbL0:AkzsYyczbVQ:F7zBnMyn0Lo" border="0"></img> (http://feeds.reuters.com/~ff/reuters/businessNews?a=IFmsFJoNbL0:AkzsYyczbVQ:F7zBnMyn0Lo) <img src="http://feeds2.feedburner.com/~ff/reuters/businessNews?i=IFmsFJoNbL0:AkzsYyczbVQ:V_sGLiPBpWU" border="0"></img> (http://feeds.reuters.com/~ff/reuters/businessNews?a=IFmsFJoNbL0:AkzsYyczbVQ:V_sGLiPBpWU)
</div><img src="http://feeds2.feedburner.com/~r/reuters/businessNews/~4/IFmsFJoNbL0" height="1" width="1"/>
http://feeds.reuters.com/~r/reuters/businessNews/~3/IFmsFJoNbL0/idUSTRE5285NO20090309